TEST BANK
KARCH’S FOCUS ON NURSING PHARMACOLOGY, 9TH EDITION
by Rebecca Tucker
,TABLE OF CONTENT
Chapter 1, Introduction to Drugs ......................................................................................................................... 4
Chapter 2, Drugs and the Body .......................................................................................................................... 20
Chapter 3, Toxic Effects of Drugs ..................................................................................................................... 35
Chapter 4, The Nursing Process in Drug Therapy and Patient Safety ............................................................... 50
Chapter 5, Dosage Calculations ......................................................................................................................... 64
Chapter 6, Challenges to Effective Drug Therapy ............................................................................................. 78
Chapter 7, Introduction to Cell Physiology ....................................................................................................... 93
Chapter 8, Anti-Infective Agents ..................................................................................................................... 107
Chapter 9, Antibiotics ...................................................................................................................................... 122
Chapter 10, Antiviral Agents ........................................................................................................................... 138
Chapter 11, Antifungal Agents ........................................................................................................................ 151
Chapter 12, Antiprotozoal Agents ................................................................................................................... 167
Chapter 13, Anthelmintic Agents .................................................................................................................... 182
Chapter 14, Antineoplastic Agents .................................................................................................................. 197
Chapter 15, Introduction to the Immune Response and Inflammation ............................................................ 212
Chapter 16, Antiinflammatory, Antiarthritis, and Related Agents .................................................................. 227
Chapter 17, Immune Modulators ..................................................................................................................... 242
Chapter 18, Vaccines and Sera ........................................................................................................................ 257
Chapter 19, Introduction to Nerves and the Nervous System .......................................................................... 271
Chapter 20, Anxiolytic and Hypnotic Agents .................................................................................................. 286
Chapter 21, Antidepressant Agents.................................................................................................................. 301
Chapter 22, Psychotherapeutic Agents ............................................................................................................ 317
Chapter 23, Antiseizure Agents ....................................................................................................................... 327
Chapter 24, Antiparkinsonism Agents ............................................................................................................. 342
Chapter 25, Muscle Relaxants ......................................................................................................................... 357
Chapter 26, Opioid Agonists, Opioid Antagonists, and Antimigraine Agents ................................................ 371
Chapter 27, General and Local Anesthetic Agents .......................................................................................... 385
Chapter 28, Neuromuscular Junction Blocking Agents ................................................................................... 400
Chapter 29, Introduction to the Autonomic Nervous System .......................................................................... 416
Chapter 30, Adrenergic Agonists ..................................................................................................................... 431
Chapter 31, Adrenergic Antagonists ................................................................................................................ 446
Chapter 32, Cholinergic Agonists .................................................................................................................... 461
Chapter 33, Anticholinergic Agents ................................................................................................................ 476
Chapter 34, Introduction to the Endocrine System .......................................................................................... 492
Chapter 35, Hypothalamic and Pituitary Agents ............................................................................................. 506
Chapter 36, Adrenocortical Agents.................................................................................................................. 521
Chapter 37, Thyroid and Parathyroid Agents .................................................................................................. 537
,Chapter 38, Agents to Control Blood Glucose Levels ..................................................................................... 551
Chapter 39, Introduction to the Reproductive System ..................................................................................... 567
Chapter 40, Drugs Affecting the Female Reproductive System ...................................................................... 583
Chapter 41, Drugs Affecting the Male Reproductive System ......................................................................... 598
Chapter 42, Introduction to the Cardiovascular System .................................................................................. 613
Chapter 43, Drugs Affecting Blood Pressure .................................................................................................. 628
Chapter 44, Agents for Treating Heart Failure ................................................................................................ 645
Chapter 45, Antiarrhythmic Agents ................................................................................................................. 661
Chapter 46, Antianginal Agents ....................................................................................................................... 675
Chapter 47, Lipid-Lowering Agents ................................................................................................................ 690
Chapter 48, Drugs Affecting Blood Coagulation ............................................................................................ 705
Chapter 49, Drugs Used to Treat Anemias ...................................................................................................... 720
Chapter 50, Introduction to the Renal System ................................................................................................. 735
Chapter 51, Diuretic Agents ............................................................................................................................ 750
Chapter 52, Drugs Affecting the Urinary Tract and the Bladder ..................................................................... 764
Chapter 53, Introduction to the Respiratory System ........................................................................................ 779
Chapter 54, Drugs Acting on the Upper Respiratory Tract ............................................................................. 795
Chapter 55, Drugs Acting on the Lower Respiratory Tract ............................................................................. 811
Chapter 56, Introduction to the Gastrointestinal System ................................................................................. 826
, Chapter 1, Introduction to Drugs
1. A nurse working in radiology administers iodine to a client who is having a computed
tomography (CT) scan. The nurse working on the oncology unit administers chemotherapy
to clients who have cancer. At the Public Health Department, a nurse administers a
measles–mumps–rubella (MMR) vaccine to a 14-month-old child as a routine
immunization. Which branch of pharmacology best describes the actions of all three nurses?
a. pharmacoeconomics
b. pharmacotherapeutics
c. pharmacodynamics
d. pharmacokinetic
ANS: B
Feedback: Pharmacology is the study of the biologic effects of chemicals. Nurses are
involved with clinical pharmacology or pharmacotherapeutics, which is a branch of
pharmacology that deals with the uses of drugs to treat, prevent, and diagnose disease. The
radiology nurse is administering a drug to help diagnose a disease. The oncology nurse is
administering a drug to help treat a disease. Pharmacoeconomics includes any costs
involved in drug therapy. Pharmacodynamics involves how a drug affects the body, and
pharmacokinetics is how the body acts on the body.
PTS: 1 DIF: Moderate REF: Page and Header: 3, Introduction
OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1 KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Analyze NOT: Multiple Choice
2. The care provider has prescribed intravenous hydromorphone, an opioid, for a client using a
client-controlled analgesia (PCA) pump. The nurse is aware that this drug has a high abuse
potential. Under what category would hydromorphone be classified?
a. schedule I
b. schedule II
c. schedule III
d. shedule IV
ANS: B
Feedback: Opioids with a high abuse potential are classified as schedule II drugs because of
severe dependence liability. Schedule I drugs have high abuse potential and no accepted
medical use. Schedule III drugs have a lesser abuse potential than schedule II drugs and an
accepted medical use. Schedule IV drugs have low abuse potential and limited dependence
liability.
PTS: 1 DIF: Easy
REF: Page and Header: Legal Regulation of Drugs, 19, Box 1.2
OBJ: 3
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple
KARCH’S FOCUS ON NURSING PHARMACOLOGY, 9TH EDITION
by Rebecca Tucker
,TABLE OF CONTENT
Chapter 1, Introduction to Drugs ......................................................................................................................... 4
Chapter 2, Drugs and the Body .......................................................................................................................... 20
Chapter 3, Toxic Effects of Drugs ..................................................................................................................... 35
Chapter 4, The Nursing Process in Drug Therapy and Patient Safety ............................................................... 50
Chapter 5, Dosage Calculations ......................................................................................................................... 64
Chapter 6, Challenges to Effective Drug Therapy ............................................................................................. 78
Chapter 7, Introduction to Cell Physiology ....................................................................................................... 93
Chapter 8, Anti-Infective Agents ..................................................................................................................... 107
Chapter 9, Antibiotics ...................................................................................................................................... 122
Chapter 10, Antiviral Agents ........................................................................................................................... 138
Chapter 11, Antifungal Agents ........................................................................................................................ 151
Chapter 12, Antiprotozoal Agents ................................................................................................................... 167
Chapter 13, Anthelmintic Agents .................................................................................................................... 182
Chapter 14, Antineoplastic Agents .................................................................................................................. 197
Chapter 15, Introduction to the Immune Response and Inflammation ............................................................ 212
Chapter 16, Antiinflammatory, Antiarthritis, and Related Agents .................................................................. 227
Chapter 17, Immune Modulators ..................................................................................................................... 242
Chapter 18, Vaccines and Sera ........................................................................................................................ 257
Chapter 19, Introduction to Nerves and the Nervous System .......................................................................... 271
Chapter 20, Anxiolytic and Hypnotic Agents .................................................................................................. 286
Chapter 21, Antidepressant Agents.................................................................................................................. 301
Chapter 22, Psychotherapeutic Agents ............................................................................................................ 317
Chapter 23, Antiseizure Agents ....................................................................................................................... 327
Chapter 24, Antiparkinsonism Agents ............................................................................................................. 342
Chapter 25, Muscle Relaxants ......................................................................................................................... 357
Chapter 26, Opioid Agonists, Opioid Antagonists, and Antimigraine Agents ................................................ 371
Chapter 27, General and Local Anesthetic Agents .......................................................................................... 385
Chapter 28, Neuromuscular Junction Blocking Agents ................................................................................... 400
Chapter 29, Introduction to the Autonomic Nervous System .......................................................................... 416
Chapter 30, Adrenergic Agonists ..................................................................................................................... 431
Chapter 31, Adrenergic Antagonists ................................................................................................................ 446
Chapter 32, Cholinergic Agonists .................................................................................................................... 461
Chapter 33, Anticholinergic Agents ................................................................................................................ 476
Chapter 34, Introduction to the Endocrine System .......................................................................................... 492
Chapter 35, Hypothalamic and Pituitary Agents ............................................................................................. 506
Chapter 36, Adrenocortical Agents.................................................................................................................. 521
Chapter 37, Thyroid and Parathyroid Agents .................................................................................................. 537
,Chapter 38, Agents to Control Blood Glucose Levels ..................................................................................... 551
Chapter 39, Introduction to the Reproductive System ..................................................................................... 567
Chapter 40, Drugs Affecting the Female Reproductive System ...................................................................... 583
Chapter 41, Drugs Affecting the Male Reproductive System ......................................................................... 598
Chapter 42, Introduction to the Cardiovascular System .................................................................................. 613
Chapter 43, Drugs Affecting Blood Pressure .................................................................................................. 628
Chapter 44, Agents for Treating Heart Failure ................................................................................................ 645
Chapter 45, Antiarrhythmic Agents ................................................................................................................. 661
Chapter 46, Antianginal Agents ....................................................................................................................... 675
Chapter 47, Lipid-Lowering Agents ................................................................................................................ 690
Chapter 48, Drugs Affecting Blood Coagulation ............................................................................................ 705
Chapter 49, Drugs Used to Treat Anemias ...................................................................................................... 720
Chapter 50, Introduction to the Renal System ................................................................................................. 735
Chapter 51, Diuretic Agents ............................................................................................................................ 750
Chapter 52, Drugs Affecting the Urinary Tract and the Bladder ..................................................................... 764
Chapter 53, Introduction to the Respiratory System ........................................................................................ 779
Chapter 54, Drugs Acting on the Upper Respiratory Tract ............................................................................. 795
Chapter 55, Drugs Acting on the Lower Respiratory Tract ............................................................................. 811
Chapter 56, Introduction to the Gastrointestinal System ................................................................................. 826
, Chapter 1, Introduction to Drugs
1. A nurse working in radiology administers iodine to a client who is having a computed
tomography (CT) scan. The nurse working on the oncology unit administers chemotherapy
to clients who have cancer. At the Public Health Department, a nurse administers a
measles–mumps–rubella (MMR) vaccine to a 14-month-old child as a routine
immunization. Which branch of pharmacology best describes the actions of all three nurses?
a. pharmacoeconomics
b. pharmacotherapeutics
c. pharmacodynamics
d. pharmacokinetic
ANS: B
Feedback: Pharmacology is the study of the biologic effects of chemicals. Nurses are
involved with clinical pharmacology or pharmacotherapeutics, which is a branch of
pharmacology that deals with the uses of drugs to treat, prevent, and diagnose disease. The
radiology nurse is administering a drug to help diagnose a disease. The oncology nurse is
administering a drug to help treat a disease. Pharmacoeconomics includes any costs
involved in drug therapy. Pharmacodynamics involves how a drug affects the body, and
pharmacokinetics is how the body acts on the body.
PTS: 1 DIF: Moderate REF: Page and Header: 3, Introduction
OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
TOP: Chapter: 1 KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Analyze NOT: Multiple Choice
2. The care provider has prescribed intravenous hydromorphone, an opioid, for a client using a
client-controlled analgesia (PCA) pump. The nurse is aware that this drug has a high abuse
potential. Under what category would hydromorphone be classified?
a. schedule I
b. schedule II
c. schedule III
d. shedule IV
ANS: B
Feedback: Opioids with a high abuse potential are classified as schedule II drugs because of
severe dependence liability. Schedule I drugs have high abuse potential and no accepted
medical use. Schedule III drugs have a lesser abuse potential than schedule II drugs and an
accepted medical use. Schedule IV drugs have low abuse potential and limited dependence
liability.
PTS: 1 DIF: Easy
REF: Page and Header: Legal Regulation of Drugs, 19, Box 1.2
OBJ: 3
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple
